USA-- Matthews & Associates filed the country’s first post blackbox lawsuits, in October, against the makers of Reglan, a gastrointestinal drug known to cause a neurological syndrome called Tardive Dyskinesia.

The firm filed eight Reglan lawsuits in the Philadelphia Court of Common Pleas against Teva Pharmaceuticals, Inc. and three in California Superior Court in Riverside County against Watson Laboratories, Inc.. All lawsuits included the original creators of Reglan, Wyeth Pharmaceutical Company. Reglan has been on the market since the 1980s, but generic versions also exist. In February 2009, the FDA cautioned about the key ingredient, metoclopramide:

"Chronic use of metoclopramide has been linked to tardive dyskinesia, which may include involuntary and repetitive movements of the body, such as lip smacking, grimacing, tongue protrusion, rapid eye movements or blinking, puckering and pursing of the lips, or impaired movement of the fingers, even after the drugs are no longer taken. These symptoms are rarely reversible and there is no known treatment."

If you or a loved one were injured or are suffering from symptoms as a result of Reglan Use, contact Matthews & Associates for a free consultation.